





























Link to publication record in King's Research Portal
Citation for published version (APA):
Brailey, P. M., Lebrusant Fernandez, M., & Barral, P. (2020). NKT cells and the regulation of intestinal immunity:
A two-way street. FEBS Journal, 287(9), 1686-1699. https://doi.org/10.1111/febs.15238
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 29. Jul. 2021
This article has been accepted for publication and undergone full peer review but has not been 
through the copyediting, typesetting, pagination and proofreading process, which may lead to 
differences between this version and the Version of Record. Please cite this article as doi: 
10.1111/FEBS.15238
 This article is protected by copyright. All rights reserved
Received Date : 10-Oct-2019
Revised Date   : 17-Jan-2020
Accepted Date : 03-Feb-2020
Article type      : State-of-the-Art Review
NKT CELLS AND THE REGULATION OF INTESTINAL IMMUNITY: A TWO-WAY STREET
Phillip M. Brailey1,2,*, Marta Lebrusant-Fernandez1,2,* & Patricia Barral1,2
1The Peter Gorer Department of Immunobiology. King’s College London. London, UK 
2The Francis Crick Institute. London, UK
*Equal contribution
Corresponding author: Patricia Barral
Tel: +44 (0)2037963358
E-mail: patricia.barral@kcl.ac.uk
Running title: The crosstalk between the microbiota and NKT cells










This article is protected by copyright. All rights reserved
ABBREVIATIONS
αGalCer: alpha-galactosylceramide
APC: antigen presenting cells
CD: Crohn’s disease
DC: dendritic cell
DSS: dextran sodium sulfate
GF: germ-free
IBD: Inflammatory Bowel Disease
IEC: intestinal epithelial cells
ILC: Innate lymphoid cell
mLN: mesenteric lymph node
NKT cell: Natural Killer T cell
PLZF: promyelocytic leukemia zinc finger
RORt: RAR-related orphan receptor gamma
SI: small intestine
SPF: specific pathogen free
TCR: T cell receptor
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ABSTRACT
The mammalian gastrointestinal compartment is colonised by millions of microorganisms that 
have a central influence on human health. Intestinal homeostasis requires a continuous dialogue 
between the commensal bacteria and intestinal immune cells. While interactions between host 
and commensal bacteria are normally beneficial, allowing training and functional tuning of 
immune cells, dysregulated immune system-microbiota crosstalk can favour the development of 
chronic inflammatory diseases, as it is the case for inflammatory bowel disease (IBD). Natural 
Killer T (NKT) cells, which recognize CD1-restricted microbial and self-lipids, contribute to the 
regulation of mucosal immunity by controlling intestinal homeostasis and participating in the 
development of IBD. Here, we provide an overview of the recently identified pathways underlying 
the crosstalk between commensal bacteria and NKT cells and discuss the effect of these 
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INTRODUCTION
The mammalian gastrointestinal mucosa is a unique environment colonised by a highly complex 
mixture of microorganisms that establish a mutualistic relationship with the host. The defence 
system of the intestinal mucosa comprises an epithelial layer and a plethora of immune cells that 
restrict commensals within the intestine while preserving their number and diversity. Conversely, 
commensal organisms are required for the development of a fully functional immune system [1]. 
While interactions between host and commensal bacteria are normally beneficial, it is becoming 
clear that dysregulated immune system-microbiota crosstalk can favour the development of 
chronic inflammatory diseases such as inflammatory bowel disease (IBD). Metagenomic 
sequencing studies reveal alterations in the populations of commensal bacteria (dysbiosis) in 
patients suffering from IBD. Moreover, studies in murine models provide a causal link between 
changes in commensal populations and the pathogenesis and progression of intestinal 
inflammation [2]. The factors triggering the development of IBD are incompletely understood, but 
the balance between health and disease is most likely regulated by the interactions between 
immune cells and commensal microbes. Hence, deciphering the mechanisms that mediate the 
communications between microbial communities and immune cells could provide approaches to 
prevent or ameliorate intestinal disorders, with potential relevance to immunopathologies more 
generally.
Whilst much gut immunology research has focused on the function of conventional MHC-
restricted T cells, recent studies have revealed a central role for CD1-restricted, lipid-reactive 
Natural Killer T (NKT) cells in the regulation of intestinal immunity. NKT cells are present in 
mouse and human gut where they recognise commensal-derived lipids and participate in the 
control of intestinal homeostasis and inflammation. In this review we will summarise the 
mechanisms underlying the crosstalk between the commensal microbiota and NKT cells and 
discuss how these interactions shape mucosal immunity in health and disease.
NKT CELLS: AN OVERVIEW
The mammalian immune system has evolved to protect hosts from a vast variety of threats 
through the evolutionarily “ancient” innate immunity and the “modern” adaptive immunity. NKT 
cells fall at the crossroads of these two immune paradigms, capable of recognising antigens 
through their T cell receptor (TCR), but responding rapidly in an innate-like manner. These 
abilities warrant NKT cells a place within the “unconventional T cell” family, along with MAIT cells 
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NKT cell development and classification
NKT cells were originally identified by the expression of NK markers as well as their TCR, and 
later defined for their capacity to recognise lipid antigens presented by the MHC-I-like molecule 
CD1 [3, 5]. CD1 molecules encompass a family of lipid-presenting proteins (CD1a-d in humans, 
with only CD1d expressed in mice) that vary in the structure of their lipid binding grooves, 
patterns of cellular expression and intracellular trafficking [3, 6]. Within the thymus 
CD1+CD4+CD8+ thymothytes participate in the selection of NKT cells that will consequently 
become CD1 restricted [7]. While CD1 is strictly required for NKT cell development, the nature of 
the lipid ligands involved in NKT cell selection remains unclear and controversial [8, 9]. Based on 
their CD1 restriction and TCR specificity NKT cells can be classified in two families [4]: type I or 
type II NKT cells. Type I NKT cells - also known as invariant NKT (iNKT) cells - express a semi-
invariant TCR (typically V14-J18 in mice and V24-J18 in humans) and recognise the lipid α-
galactosylceramide (αGalCer) presented by CD1d. These cells can be identified using αGalCer-
loaded CD1d tetramers, and they have been the most studied group up to date. Despite their 
limited TCRα usage, iNKT cells recognise diverse endogenous and exogenous lipid antigens. 
Recognition of diverse lipids is partially dependent on the TCRVβ usage but also on variations of 
the polymorphic CDR3β region [10-12]. On the other hand, type II NKT cells are not reactive to 
αGalCer and recognise a variety of lipids presented by the different CD1 molecules (CD1a-d) 
[13]. A proportion of type II NKT cells recognises the naturally occurring self-glycolipid sulfatide 
and has an oligoclonal TCR repertoire [14]. However, sulfatide-loaded CD1d tetramers have not 
been widely used to characterize type II NKT cells due to high background staining. As they lack 
a defining marker, the function of type II NKT cells in mice is usually deduced by comparing the 
phenotype of CD1d-deficient mice (which lack type I and II NKT cells) with Jα18-deficient mice 
(which lack type I NKT cells).
iNKT cell functional subsets 
iNKT cells show a wide tissue distribution but, unlike conventional T cells, the majority of iNKT 
cells don’t recirculate but instead establish long-term residency within the tissues [15-18]. In 
peripheral tissues of mice, we can find several functional subsets of iNKT cells that are classified 
on the basis of their transcription factor expression and their cytokine secretion patterns (Table 
1): NKT1 (T-bet+), NKT2 (PLZFhi), NKT17 (RORt+), NKT10 (E4BP4+), NKTreg (Foxp3+) and NKT 
follicular helper cells (NKTFH, Bcl6+). NKT1, NKT2 and NKT17 are found at different proportions in 
various lymphoid and non-lymphoid tissues in homeostatic conditions [19-21]. In C57Bl/6 mice 
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are abundant in mesenteric lymph node (mLN), and NKT17 cells are enriched in lungs as well as 
in inguinal, axillary and cervical LNs [20]. NKT10 preferentially accumulate in adipose tissue in 
homeostasis, but can be induced in response to immunisation and are found in the intestine of 
transgenic mouse models of colorectal cancer (APCMin/+ mice) [18, 22, 23]. On the other hand, 
NKTFH and NKTregs have been only detected in mice during immune responses [24, 25]. In 
agreement with their distinct phenotype, iNKT cells found in various tissues have unique 
functions that contribute to modulate the outcome of immunity [16]. For instance, in the lung-
draining LNs iNKT cells are major producers of IL-4 and defend against viral infection [26], while 
adipose tissue iNKT cells secrete IL-10 and protect from inflammation-induced obesity [18]. 
While the preferential tissue distribution of the various iNKT cell subsets is well stablished, the 
mechanisms controlling their differentiation in the thymus and/or the periphery remain 
incompletely understood. Several (but non-exclusive) scenarios could contribute to explain the 
differential presence of iNKT cell subsets in various anatomical locations: (i) iNKT cells commit in 
the thymus before migrating to peripheral tissues; (ii) uncommitted iNKT cells emigrate from the 
thymus and differentiate in peripheral tissues; (iii) functionally committed iNKT cells display 
plasticity in response to specific signals and/or (iv) certain iNKT cell subsets can preferentially 
expand in response to signals in the tissues or during an immune response. A broad range of 
literature backs these various scenarios. For instance, in support of thymic commitment it has 
been shown that the TCR signal strength during thymic development can direct the differentiation 
of iNKT cells within specific functional subsets [27]. Further to this, a variety of signalling 
molecules and transcription factors including Zap70, Bcl11b or Roquin have been shown to 
participate in the control of iNKT cell lineage differentiation [28-30]. On the other hand, several 
lines of evidence suggest that iNKT cells can acquire functional capabilities in the periphery. For 
instance, earlier studies showed that non-committed iNKT cells can be induced to produce IL-9 or 
IL-17 in response to cytokine stimulation [31, 32]. Also, it has been recently shown that 
undifferentiated PLZFhiCCR7+ iNKT cell precursors can emigrate from the thymus to the 
periphery where they terminally differentiate into one of the iNKT cell subsets [33]. These iNKT 
cell precursors are found in various peripheral tissues and show a phenotype and TCR repertoire 
distinct from that of mature iNKT cells [12, 33, 34]. Finally, specific iNKT cell subsets can expand 
in various tissues in response to lipid antigen administration. For instance, NKT2 cells expand in 
the mLN in response to oral lipids, while pre-treatment with GalCer induces the expansion of 
NKT10 cells in the spleen [22, 35]. Thus, all together this data suggests that while thymic signals 
modulate the commitment of iNKT cells to one of the functional subsets it is likely that peripheral 
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iNKT cell activation
NKT cells can get activated through antigen-dependent and independent mechanisms and in 
response to foreign or self-lipids (Figure 1). CD1d-mediated presentation of exogenous lipid 
antigens to iNKT cells leads to their activation and rapid cytokine production [36]. For instance, 
iNKT cells can recognise and be activated by CD1d-restricted foreign lipids either synthetic or 
found in pathogenic bacteria (e.g. Streptococcus pneumonia, Borrelia Burgdorgferi), commensals 
(Bacteroides fragilis), fungi (Aspergillus fumigatus) or allergenic sources (pollens) [37-40]. Co-
stimulatory molecules can positively (e.g. ICOS, CD40L, CD28) or negatively (e.g. PD-1, BTLA, 
LAG-3) influence iNKT cell activation and skew the immune response [41]. In the absence of 
exogenous lipids, iNKT cells can also be activated by self-lipids in a variety of contexts [42]. For 
instance, in the presence of innate-like signals (e.g. during viral infection) activation of iNKT cells 
can still occur in a CD1d-dependent manner. In this case, Toll like receptor (TLR) stimulation of 
antigen presenting cells (APCs) induces changes in lipid biosynthesis and accumulation of 
endogenous lipids which are presented on CD1d and mediate iNKT cell activation [8, 43-45]. 
Lastly, cytokines can further enhance TCR-dependent responses and, in some instances, iNKT 
cells can be activated solely in response to cytokine stimulation (e.g. IL-12, IL-18) [36, 46, 47]. 
Importantly, these mechanisms of activation are not mutually exclusive. In some instances, 
despite the presence of CD1d-restricted lipid antigens, cytokine-driven signals - rather than 
cognate antigens - dictate iNKT cell activation as it has been shown during infections with 
Sphingomonas yanoikuyae or Streptococcus pneumoniae [48].
NKT CELLS IN THE INTESTINAL COMPARTMENT 
The gastrointestinal tract constitutes one of the most complex antigenic environments in the body 
as it is not only continually exposed to dietary products but it is also densely populated with a vast 
array of intestinal bacteria. As a result, the intestine is equipped with a highly specialised immune 
system that is key for maintaining the segregation between the host and bacteria consequently 
controlling tissue homeostasis [1]. Containment of commensals within the intestine is achieved by 
an epithelial layer together with populations of B cells, T cells, macrophages, dendritic cells (DCs) 
and various innate immune cells including unconventional T cells. 
NKT cells are found in the intestine of mice and humans. In humans, iNKT cells are present at 
high frequencies in the foetal intestine while in mice intestinal iNKT cells are absent at birth but 
their frequency increases over the first 6 weeks of age [49-51]. In the gut of adult mice iNKT cells 
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iNKT cell numbers inversely correlate with both bacterial density and bacterial proximity, and thus 
iNKT cells are more prevalent in the small intestine (SI) than in the colon and more highly 
represented in the lamina propria than in the epithelial layer [35, 52]. As it is the case in most 
peripheral tissues, NKT1 cells are prevalent in the intestinal tract representing around ~85% of 
iNKT cells in the SI, colon and Peyer’s Patches of C57BL/6 mice, with the rest of the cells 
belonging to NKT17 (~10%) and NKT2 (<5%) families [35, 53]. NKT1 cells are also prevalent in 
the gut-draining mesenteric lymph nodes (mLN), although there is an increased presence of 
NKT2s (~40%) in this tissue. Consistent with this, NKT cells are the major producers of IL-4 in 
this tissue and after stimulation of mLN lymphocytes with PMA/ionomycin iNKT cells constitute up 
to 60% of the IL-4 producing cells [35]. Finally, NKT10 cells are also found in the intestine of 
transgenic mouse models of colorectal cancer (APCMin/+ mice) [23]. It is worth noting that while the 
majority of iNKT cells found in the adult murine gut in steady-state are T-bet+ NKT1s, it is possible 
that other iNKT cell subsets (or precursors) could be recruited/expanded under certain 
inflammatory conditions ultimately shaping the functional capabilities of the local iNKT cell 
population. 
Regulation of NKT cells’ homeostasis by the microbiota
It is increasingly appreciated that commensal-derived products regulate the homeostasis and 
function of most immune cell populations. Commensal bacteria represent a major source of lipids, 
several of which have been identified for their capacity to activate iNKT cells. Indeed, cumulative 
evidence demonstrates that the microbiota provides key signals for modulating intestinal iNKT 
cell numbers and phenotype, although iNKT cells are present in the intestine even in the absence 
of microbiota [50, 52, 54]. In homeostatic conditions iNKT cells from the gut and mLN (but not 
from spleen or liver) express high levels of the transcription factor Nur77 (as detected in reporter 
mice), suggesting that intestinal iNKT cells are recognising lipid antigens in a TCR-dependent 
manner [35, 55]. The influence of microbial-derived products in the control of the iNKT cell 
population was confirmed in experiments with germ-free (GF) mice, where iNKT cells are present 
at higher numbers in the colon and exhibit a less mature phenotype in comparison with cells from 
Specific Pathogen free (SPF) mice [50, 52]. The effect of the microbiota on the iNKT cell 
population seems to be particularly important early in life as iNKT cells proliferate and accumulate 
in the intestine of neonatal GF mice in a process that is negatively regulated by exposure to 
commensals [50, 51]. Not only the presence/absence but also the composition of the commensal 
bacteria can have profound effects on iNKT cells. For instance, short-term antibiotic treatment is 
sufficient to induce the expansion of colonic iNKT cells and to alter their cytokine profile [56]. 
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proinflammatory phenotype on colonic iNKT cells [56]. Strikingly, the gut microbiome is also able 
to regulate iNKT cells in distal tissues including the spleen, liver and thymus [52, 54]. iNKT cells 
in these tissues of mice from different vendors with known variation in their intestinal bacteria 
(Taconic vs. Jacksons), differ in their frequency, phenotype, TCRV usage and cytokine secretion 
while these differences disappear after co-housing of the mice [52]. Moreover, the liver is 
exposed to gut-derived products through the portal vein and the microbiome can use bacterial 
bile acid metabolites as messengers to cause the accumulation of hepatic CXCR6-expressing 
iNKT cells. As a result, these cells present a more activated phenotype and mediate the inhibition 
of hepatic tumour growth [57].  
Although the microbial-derived lipids that might be involved in the regulation and maintenance of 
the iNKT cell population in the gut remain largely uncharacterised, several key bacteria have 
been identified in recent years. Sphingomonas, which are commensal species in the gut, contain 
glycosylceramides on the cell wall that can serve as antigens for iNKT cells [8, 58, 59]. Indeed, 
iNKT cells from GF mice show an immature phenotype which is rescued after colonisation with 
Sphingomonas but not with E. coli (which lack glycosylceramides) [52]. Members of the 
Bacteroides genus may be crucial for regulating the iNKT cell population as 40-70% of their 
membrane phospholipids are sphingolipids, which could be presented to iNKT cells by CD1d. 
Indeed, an isoform of αGalCer is produced by B. fragilis. This sphingolipid was shown to activate 
and elicit IFN- production both in mouse and human iNKT lymphocytes in a CD1d-depedent 
manner [38]. Conversely, B. fragilis has been reported to have a direct effect on the homeostasis 
of colonic iNKT cells by providing inhibitory sphingolipids that negatively modulate cell 
proliferation in the neonatal period [51]. Interestingly, the presence of αGalCers in the murine 
intestinal compartment is strongly decreased in response to Western type diet, DSS-induced 
colitis or Influenza A virus infection, potentially impacting the function of intestinal iNKT cells [60]. 
Altogether these studies support a model by which the commensal microbiota can control the 
iNKT cell compartment by providing either inhibitory or stimulatory lipid antigens. Nonetheless it is 
likely that other signals in the intestinal environment such as cytokines, neurotransmitters or 
dietary components also contribute to the control of the intestinal iNKT cell population, although 
the nature and the mechanism of action of such signals remain unknown.
Besides microbial-derived antigens, key players in the modulation of intestinal immunity are the 
various populations of antigen presenting cells (APC) found in the intestinal compartment, which 
can differentially control tolerogenic and inflammatory responses. Indeed, the context of lipid 
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controlling the activation, proliferation and the pattern of cytokine secretion of iNKT cells [61]. 
CD1d is expressed by numerous cells in the gut including B cells, dendritic cells (DC), 
macrophages, intestinal epithelial cells (IECs) and innate lymphoid cells (ILCs), all of which can 
efficiently internalise lipid antigens and present them to iNKT cells. Direct evidence regarding the 
role of lipid presentation by APCs in the control of intestinal iNKT cells comes from conditional 
CD1d-KO mice. Experiments with these mice demonstrate that CD1d expression in CD11c+ cells 
(including DCs and macrophages) controls the phenotype of intestinal iNKT cells as mice with a 
conditional deletion of CD1d on CD11c+ cells have a decrease in the frequency of NKT17 cells in 
the SI and mLN [35]. Moreover, CD11c+ cells also control the activation of intestinal iNKT cells 
after oral administration of αGalCer [35]. While the function of other CD1d+ cells in the regulation 
of intestinal iNKT cell homeostasis remains unexplored, it is likely that various cell types 
collaborate to positively or negatively control iNKT cell immunity in the gut. For instance, group 3 
ILCs (ILC3) have been shown to mediate the peripheral selection of CD4+ T cells by inducing 
MHC-mediated cell death of activated commensal bacteria-specific T cells [62, 63]. Since ILC3s 
express CD1d and are able to present lipid antigens [64], it is tempting to speculate that they 
could also participate in the control of the intestinal iNKT cell population by CD1-mediated 
presentation of commensal-derived lipids.
NKT cells in the maintenance of intestinal homeostasis
iNKT cells play an important role in the host enteric defence and maintenance of barrier function 
in the intestine both by controlling microbial colonisation and by orchestrating the function of other 
intestinal cells (Figure 2). There are accumulating lines of evidence that support a bidirectional 
interaction between gut iNKT cells and the intestinal microbiota and consequently iNKT 
lymphocytes can also influence the composition of the commensal bacterial populations. In fact, 
CD1d-KO mice have a different microbiota than WT littermates and intragastric administration of 
various bacterial species (including Pseudomonas aeruginosa or E. coli) results in increased 
colonisation of the SI in CD1d-KO mice compared with WT mice [35, 65]. Interestingly, the 
changes in commensal microbiota detected in CD1d-KO mice are recapitulated in mice with a 
conditional deletion of CD1d on CD11c+ cells, suggesting that the crosstalk between NKT cells 
and DCs/macrophages controls the intestinal microbial populations [35]. 
Several mechanisms are in place in the intestinal compartment to minimise the direct contact 
between intestinal bacteria and the epithelial cell surface. These include the presence of a mucus 
layer secreted by Goblet cells and the production of anti-microbial peptides by IEC. iNKT cells 
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segregation between IECs and the microbiota as CD1d-KO mice show altered bacterial 
stratification, with commensal bacteria found in close proximity to IEC [35, 65]. While the 
mechanisms controlling this phenotype haven’t been fully elucidated it has been suggested that 
iNKT cells could modulate Paneth cell degranulation (and consequently anti-microbial peptide 
secretion) through production of IFN-γ [66]. Accordingly, CD1d-KO mice present a defect in 
Paneth cell’s granule ultrastructure and ability to degranulate after bacterial colonisation [65]. 
Besides IECs, intestinal iNKT cells can directly (through CD1d-mediated interactions) or indirectly 
control the function of other intestinal immune cells with potential consequences for intestinal 
homeostasis. For instance, it is well established that NKT cells can control antibody production by 
B cells [24, 67-69]. In the intestine, IgA is the most abundant antibody contributing to bacterial 
stratification, and together with IgG they cooperate to modulate intestinal immunity [70, 71]. A 
population of tissue-resident iNKT cells has been recently described in the Peyer’s patches and 
seem to critically control B cell responses [53]. As such, iNKT cells produce the majority of the IL-
4 in the Peyer's patches and provide indirect help for B cell class switch to IgG1. As a result, NKT 
cell-deficient mice show decreased levels of IgG1 in faeces [53]. Alterations in the IgA repertoire 
have been also observed in CD1d-deficient mice, although these are a consequence of the 
altered microbiota present in this strain [35]. On the other hand, iNKT cells indirectly modulate the 
intestinal Treg population, which is known to play a critical role in the regulation of intestinal 
homeostasis [72]. As such, Treg numbers and frequencies are altered in the mLN and SI of 
CD1d-KO mice vs. littermate controls, while activation of iNKT cells in response to oral αGalCer 
results in increased numbers of peripherally induced Tregs [35]. Moreover, a population of 
regulatory iNKT cells in the intestine has been shown to locally promote intestinal polyp formation 
by enhancing Treg cell frequency in a mouse model of colorectal cancer [23]. Finally, CD1d-
mediated NKT cell-APC interactions can also modulate APC activation and function and 
ultimately shape intestinal immunity. For instance, engagement of CD1d on ILC3s induces 
secretion of IL-22 [64], which in turn supports epithelial barrier and promotes barrier defence 
mechanisms against bacterial pathogens [73]. Also, ligation of CD1d on IEC leads to production 
of IL-10 which protects from intestinal inflammation [74]. All together these studies propose NKT 
cells/CD1 as central players in the maintenance of intestinal homeostasis by modulating the 
composition and stratification of the intestinal commensal bacteria as well as the function of 
immune and epithelial cells.
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Given their importance in gut homeostasis, the role of NKT cells during intestinal disease is under 
increased investigation. In fact, NKT cells have been identified as major players in intestinal 
inflammation in mice and humans. IBD represents a group of intestinal disorders that cause 
prolonged inflammation of the digestive tract. The aetiology of IBD is unclear, with genetics, 
environmental/lifestyle factors and microbiota associated with increased risk. IBD can be 
classified in two major forms of disease -ulcerative colitis (UC) and Crohn’s disease (CD)- which 
differ in the extent of pathology and in their immune profile. In general terms immune responses 
are thought to be predominantly Th1 for CD and Th2 for UC [75], although it is worth noting that 
this is a somewhat basic classification which may not fully cover the complexity of the immune 
responses in human IBD. Dysregulation of CD1 expression and NKT cell activation are 
associated with intestinal inflammation in mice and humans and suggest a complex role for these 
cells in IBD. In general, NKT cells seem to be pathogenic in Th2-like intestinal inflammation, but 
protective in Th1 models [76, 77]. 
Intestinal NKT cells contribute to the fuelling of intestinal inflammation in UC through a 
mechanism mediated by IL-13 (Figure 3). In the oxazolone model of murine UC, iNKT cells 
accumulate in the gut, whereas there is striking protection from disease in CD1d-KO, J18-KO 
and IL-13-KO mice as well as in WT mice pre-treated with anti-CD1d or anti-IL-13 blocking 
antibodies [50, 76, 78]. In this model, IL-13 secretion seems to be regulated by IL-25, as blocking 
IL-25 signalling results in decreased IL-13 levels and improved gut inflammation [79]. On the 
same line, GF mice -which have increased numbers of iNKT cells in the gut- show increased 
pathology in response to oxazolone-induced colitis, with significantly higher IL-13 secretion [50, 
51]. In humans, type II NKT cells are enriched in the mucosa from patients with UC and secrete 
IL-13 [80, 81]. The mechanisms of action for IL-13 in intestinal inflammation are not fully 
understood, but experiments with colonic cell line monolayers suggest that IL-13 can induce 
apoptosis of IECs as well as alteration of tight junction protein composition ultimately disturbing 
the intestinal barrier function [82, 83]. In the clinic, administration of monoclonal antibodies 
against IL-13 (tralokinumab) to UC patients did not significantly increase the proportion of 
patients who achieved clinical response (defined as a >3 point reduction in Mayo score), however 
it did  increase the number of patients in clinical remission (defined as a total Mayo score of <2), 
suggesting that targeting IL-13 may be beneficial in a subset of UC patients [84, 85]. 
While the role of NKT cells and IL-13 in the control of Th2-models of colitis is well established, the 
identity of the main IL-13 producers in UC remains unclear. In models of oxazolone-colitis direct 
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shown in a small proportion of mLN iNKT cells (~10%) and in ILC2s [79] while no data is 
available for colonic iNKT cells. Moreover, the vast majority of iNKT cells in SI and colon are 
NKT1 cells with only very small proportions (<5%) of NKT2 cells (which are reported to be the 
main producers of type 2 cytokines) [19, 35]. Intriguingly, in IL-13 reporter mice iNKT cells are 
poor producers of IL-13 even in settings of type 2 inflammation [86]. This effect was attributed to 
the reduced GATA-3 expression found in iNKT cells which drives production of IL-4 over IL-13 
[86]. Thus, whilst iNKT cells are critical players in oxazolone-colitis, these observations question 
whether they are the main producers of IL-13. This raises the possibility that iNKT cells could 
function by indirectly modulating the secretion of IL-13 by other cell types such as ILC2s or 
conventional CD4+ T cells. Alternatively, it is also possible that the intestinal inflammatory 
environment may induce a degree of functional plasticity on intestinal iNKT cells and/or drive the 
expansion/recruitment of iNKT cell precursors or of a population of IL-13 secreting iNKT cells that 
hasn’t been detected to date. Finally, IL-13 could be secreted by type II NKT cells in mice (as 
described in human UC patients [80]), although this scenario wouldn’t explain the protective 
phenotype of J18-KO mice in oxazolone-colitis [76]. 
Besides IL-13-mediated intestinal inflammation, NKT cells and CD1 have been also shown to 
control intestinal immunity through other mechanisms of action. For instance, CD1d-dependent 
regulation of IEC function can on itself control gut inflammation. In oxazolone-colitis IECs produce 
anti-inflammatory IL-10 in a CD1d-depedent manner critically controlling intestinal pathology [74]. 
Consequently, the deletion of CD1d in the intestinal epithelium increases oxazolone-induced 
inflammation, while non-epithelial cells contribute to pathogenic NKT cell activation [74]. 
Interestingly, oxazolone compounds can be found in microbial and industrial sources and can 
activate iNKT cells and trigger CD1d-dependent intestinal inflammatory responses [87]. On a 
different experimental setting, overexpression of CD1d in a transgenic mouse model for type II 
iNKT cells is sufficient to induce the spontaneous development of intestinal inflammation; 
suggesting that interaction of NKT cells with CD1d-expressing cells can lead to the dysregulation 
of type II NKT cell responses and subsequently contribute to the development of IBD [88]. 
While the key role of NKT cells in Th2-driven models of colitis -such as oxazolone- is well 
established, their functions in CD and CD-like mouse models remain controversial. In humans, 
iNKT cells from the lamina propria of CD patients produce pro-inflammatory TNF, IFN, IL-17A 
and IL-13 and can disrupt epithelial monolayer integrity, suggesting that they could contribute to 
disease pathology [89]. In the dextran sodium sulphate (DSS) model of IBD, NKTs have been 
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showed that CD1d-deficient mice developed similar pathology to control mice after DSS 
administration [90]. However, other studies found that iNKT cells protect against DSS induced 
colitis by secreting IL-9 or by suppressing pathogenic T cells [77, 91]. While the reason for these 
discrepancies are not completely clear, they could be related to alterations in the microbiota in 
the NKT cell-deficient strains. It has been shown that CD1d-KO mice harbour an altered intestinal 
microbiota that is associated with exacerbated intestinal inflammation at steady-state and 
following DSS treatment [92]. This altered microbiota is transmissible upon faecal transplant to 
WT mice and influences iNKT cell function during DSS colitis [92]. Strikingly, other authors have 
described a less inflammatory microbiota that aids anti-inflammatory neutrophil recruitment in 
iNKT cell-deficient mice [93]. Thus, alterations in the microbiota will have a critical influence on 
the outcome of colitis and will likely contribute to the disparate functions proposed for NKT cells in 
this disease. 
CONCLUSIONS AND FUTURE DIRECTIONS
An increasing number of studies reveal NKT cells as important modulators of homeostasis and 
inflammation in the gastrointestinal tract. NKT cells are able to control the composition of the 
intestinal microbiota and to modulate the function of other immune cells ultimately regulating 
intestinal homeostasis and the progression of inflammatory diseases. On the other hand, within 
the intestine NKT lymphocytes are exposed to a vast array of microbial-derived glycolipids, which 
markedly shape their phenotype and functions. It is thus obvious that there is a bidirectional 
communication between NKT cells and the intestinal environment that contributes to the control 
of gut immunity. Despite these advances, many questions remain open regarding the 
mechanisms controlling this crosstalk and the effect that they exert on mucosal immunity. For 
instance: Do dietary lipids, cytokines or neurotransmitters contribute to the control of intestinal 
NKT cell function? Is the antigen specificity of intestinal NKT cells regulated by commensals 
and/or altered in IBD? What are the mechanisms controlling NKT cell activation and effector 
functions in IBD? These are critical questions whose answers will provide a great leap forward in 
our understanding of host-microbiota interactions and will offer rationale for the design of new 
therapies to prevent or ameliorate intestinal disorders.
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Table 1. Properties and tissue distribution of iNKT cell subsets. Characteristic surface 
markers, transcription factors, tissue distribution and cytokine production for iNKT subsets in 
C57Bl/6 mice. Cytokines shown in bold are the prototypical cytokines secreted by each iNKT 































































n.r. n.d [24] 
NKTFH BCL6 CXCR5+, PD1+ IL-21 n.d [25] 
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FIGURE LEGENDS
Figure 1. Mechanisms of iNKT cell activation. (A) Direct activation via microbial or synthetic 
lipids: Microbial lipid antigens from bacteria (such as Sphingomonas or Borrelia) or synthetic 
lipids (such as GalCer) will be loaded in CD1d and directly recognised by the T cell receptor 
(TCR) of iNKT cells inducing their activation and cytokine secretion [37, 58]. iNKT cell activation 
in this context can be further modulated by cytokines and/or co-stimulation [41]. (B) Endogenous 
lipids + innate signals: Toll-like receptor (TLR) stimulation of antigen presenting cells (APCs) 
induces changes in lipid synthesis and presentation of endogenous lipids. TLR-stimulated APCs 
secrete IL-12 that together with endogenous lipids mediate iNKT cell activation [8, 44, 45]. (C) 
Cytokine mediated activation: Several cytokines such as IL-12, IL-18 or type I IFN are sufficient to 
induce iNKT activation in a CD1d-independent manner [46, 47].
Figure 2. NKT cells in the regulation of intestinal homeostasis. iNKT cells contribute to the 
communication between the microbiota and the intestinal immune system. Intestinal iNKT cells 
sense lipids presented by CD11c+ cells and this regulates iNKT cell homeostasis and activation 
[35]. In turn, iNKT cells modulate (both directly and indirectly) the function of other intestinal 
immune cells as well as the composition and stratification of intestinal bacteria [35, 65]. CD1d-
mediated crosstalk between iNKT cells and intestinal epithelial cells (IEC) modulates IL-10 
secretion [74], while engagement of CD1d on group 3 innate lymphoid cells (ILC3) induces IL-22 
production [64]; both of these cytokines contribute to the control of intestinal homeostasis. 
Moreover, iNKT cells indirectly regulate the intestinal Treg population [35], the secretion of IgG1 
by intestinal B cells [53] and Paneth cell (PC) degranulation [65, 66].
Figure 3. NKT cells in intestinal inflammation. In human ulcerative colitis or murine models of 
oxazolone colitis NKT cells contribute to the fueling of intestinal inflammation through a 
This article is protected by copyright. All rights reserved
mechanism mediated by IL-13 [74, 76, 79-81]. IL-13 can induce apoptosis of intestinal epithelial 
cells (IEC) and alter epithelial tight junctions which in turn will impair barrier function [82, 83].
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